newsfilter
← Latest News
Business Wire·

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated and metabolic diseases, today announced that the company